ATE471990T1 - Transkutane immunisierung gegen papillomavirus mit virusähnlichen papillomaviruspartikeln - Google Patents

Transkutane immunisierung gegen papillomavirus mit virusähnlichen papillomaviruspartikeln

Info

Publication number
ATE471990T1
ATE471990T1 AT02807461T AT02807461T ATE471990T1 AT E471990 T1 ATE471990 T1 AT E471990T1 AT 02807461 T AT02807461 T AT 02807461T AT 02807461 T AT02807461 T AT 02807461T AT E471990 T1 ATE471990 T1 AT E471990T1
Authority
AT
Austria
Prior art keywords
papillomavirus
virus
particles
transcutane
immunization against
Prior art date
Application number
AT02807461T
Other languages
English (en)
Inventor
Robert Rose
Original Assignee
Univ Rochester
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Rochester filed Critical Univ Rochester
Application granted granted Critical
Publication of ATE471990T1 publication Critical patent/ATE471990T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5258—Virus-like particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55544—Bacterial toxins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20023—Virus like particles [VLP]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
AT02807461T 2001-08-13 2002-08-09 Transkutane immunisierung gegen papillomavirus mit virusähnlichen papillomaviruspartikeln ATE471990T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US31190101P 2001-08-13 2001-08-13
US37702302P 2002-05-01 2002-05-01
PCT/US2002/025391 WO2003103570A2 (en) 2001-08-01 2002-08-09 Transcutaneous immunization against papillomavirus with papillomavirus virus-like particles

Publications (1)

Publication Number Publication Date
ATE471990T1 true ATE471990T1 (de) 2010-07-15

Family

ID=29739302

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02807461T ATE471990T1 (de) 2001-08-13 2002-08-09 Transkutane immunisierung gegen papillomavirus mit virusähnlichen papillomaviruspartikeln

Country Status (7)

Country Link
US (1) US7247433B2 (de)
EP (1) EP1425423B1 (de)
AT (1) ATE471990T1 (de)
AU (1) AU2002367977B2 (de)
CA (1) CA2457804C (de)
DE (1) DE60236806D1 (de)
WO (1) WO2003103570A2 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2196217A1 (de) 2001-09-14 2010-06-16 Cytos Biotechnology AG Verpackung von immunstimulierenden Mitteln in virusähnischen Partikeln: Herstellungsverfahren und Verwendung
US20040137004A1 (en) * 2002-03-19 2004-07-15 Glenn Gregory M Patch for transcutaneous immunization
FR2887457B1 (fr) * 2005-06-23 2007-10-05 Fond Bettencourt Schueller Vaccination par ciblage transcutane
US8778351B2 (en) 2006-08-30 2014-07-15 University Of Rochester Combined human papillomavirus VLP/gene delivery system and use thereof as a vaccine for prophylaxis and immunotherapy of infectious diseases and tumors
US8795235B2 (en) * 2006-10-06 2014-08-05 Surgiquest, Inc. Devices for and methods of performing minimally-invasive surgical procedures through a single incision
US10045860B2 (en) 2008-12-19 2018-08-14 Amicus Design Group, Llc Interbody vertebral prosthetic device with self-deploying screws
US9566165B2 (en) 2012-03-19 2017-02-14 Amicus Design Group, Llc Interbody vertebral prosthetic and orthopedic fusion device with self-deploying anchors
US8685104B2 (en) 2012-03-19 2014-04-01 Amicus Design Group, Llc Interbody vertebral prosthetic and orthopedic fusion device with self-deploying anchors
WO2015024022A2 (en) 2013-08-16 2015-02-19 University Of Rochester Designed peptides for tight junction barrier modulation
US20220249364A1 (en) 2019-06-05 2022-08-11 University Of Rochester Designed Inhibitors of Tight Junction Formation

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0217919B1 (de) 1985-04-04 1992-08-05 Georgetown University Typenspezifische papillomavirus-dns-sequenzen und peptide
DE122007000084I1 (de) 1991-07-19 2008-03-27 Univ Queensland St Lucia Impfstoff gegen Humanes Papillomavirus (Typ 18)
DE122007000099I1 (de) 1992-06-25 2008-03-27 Papillomavirus vakzine
US5437951A (en) 1992-09-03 1995-08-01 The United States Of America As Represented By The Department Of Health And Human Services Self-assembling recombinant papillomavirus capsid proteins
US5618536A (en) 1992-09-03 1997-04-08 The United States Of America As Represented By The Department Of Health And Human Services Chimeric papillomavirus-like particles
ATE492289T1 (de) 1993-03-09 2011-01-15 Univ Rochester Herstellung von menschlichen papillomavirus hbv- 11 kapsidprotein l1 und virus-ähnliche partikeln
US6153201A (en) * 1993-03-09 2000-11-28 University Of Rochester Oral immunization with papillomavirus virus-like particles
EP0922105B1 (de) 1996-07-17 2005-12-07 THE UNITED STATES GOVERNMENT as represented by THE DEPARTMENT OF HEALTH AND HUMAN SERVICES Infektiöse pseudovirale papillomavirus partikel
US5980898A (en) 1996-11-14 1999-11-09 The United States Of America As Represented By The U.S. Army Medical Research & Material Command Adjuvant for transcutaneous immunization
US6165471A (en) 1997-07-03 2000-12-26 University Of Colorado, University Technology Corporation Homogeneous human papillomavirus capsomere containing compositions, methods for manufacture, and use thereof as diagnostic, prophylactic or therapeutic agents
US6228368B1 (en) 1997-10-06 2001-05-08 Loyola University Of Chicago Papilloma virus capsomere formulations and method of use
ES2289200T3 (es) 1998-02-25 2008-02-01 The Government Of The United States, As Represented By The Secretary Of The Army Uso de mejoradores para penetracion de la piel y agentes de alteracion de barrera para mejorar la respuesta inmune transcutanea.
US6835184B1 (en) * 1999-09-24 2004-12-28 Becton, Dickinson And Company Method and device for abrading skin
CA2390999A1 (en) 1999-11-10 2001-05-17 Powderject Vaccines, Inc. Induction of mucosal immunity by vaccination via the skin route
US20010036463A1 (en) 2000-03-09 2001-11-01 Compans Richard W. Transcutaneous immunization for large particulate antigens
US6595947B1 (en) * 2000-05-22 2003-07-22 Becton, Dickinson And Company Topical delivery of vaccines
US20020193729A1 (en) 2001-04-20 2002-12-19 Cormier Michel J.N. Microprojection array immunization patch and method

Also Published As

Publication number Publication date
DE60236806D1 (de) 2010-08-05
US7247433B2 (en) 2007-07-24
WO2003103570A2 (en) 2003-12-18
WO2003103570A3 (en) 2004-02-12
AU2002367977B2 (en) 2008-06-19
EP1425423A4 (de) 2005-07-27
CA2457804A1 (en) 2003-12-18
US20050013832A1 (en) 2005-01-20
EP1425423B1 (de) 2010-06-23
EP1425423A2 (de) 2004-06-09
CA2457804C (en) 2012-10-16
WO2003103570A9 (en) 2004-05-06
AU2002367977A1 (en) 2003-12-22

Similar Documents

Publication Publication Date Title
DK1216053T3 (da) Influenzavaccine
ATE426412T1 (de) Adjuvante influenza-vakzine
DE602004028468D1 (de) Haltung von immunantworten gegen mhc-klasse-i-beschränkte epitope, für prophylaktische oder therapeutische zwecke
WO2007028047A3 (en) Immunological uses of immunodulatory compounds for vaccine and anti-infections disease therapy
ATE542829T1 (de) Impfstoff
WO2007079190A3 (en) Device and method for enhancing immune response by electrical stimulation
ATE458496T1 (de) Hiv-vakzine und anwendungsverfahren
ATE471990T1 (de) Transkutane immunisierung gegen papillomavirus mit virusähnlichen papillomaviruspartikeln
EA200500834A1 (ru) Вакцина на основе вирусоподобных частиц вируса папилломы человека 16 и вируса папилломы человека 18 l1
CL2008003808A1 (es) Componente de vacuna contra la malaria que comprende una particula inmunogena rts,s y/o una particula que se deriva de la proteina cs de una o mas cepas de p. vivax y el antigeno s de la hepatitis b o una particula inmunogena que comprende rts, csv-s y opcionalmente el antigeno s sin fusionar y un agente estabilizante ; y vacuna.
ATE460943T1 (de) Therapeutische mittel als antikrebs impfstoffadjuvantien und deren therapeutische verfahren
DK1395283T3 (da) Heterolog beskyttelse induceret ved immunisering med Invaplex-vaccine
EA200301151A1 (ru) Вакцина против натуральной оспы
EA200700017A1 (ru) Способ усиления иммунного ответа на вакцину
MX2007002659A (es) Composicion vacunal contra el virus de la hepatitis c.
WO2007016715A3 (en) Immune response inducing preparations
EP1790332A4 (de) Vakzine zur oralen verabreichung
TW200740457A (en) Vaccine
ATE526035T1 (de) Tollwut-impfstoff
AP2003002867A0 (en) Immune response potentiation
ATE431745T1 (de) Ltb4 als adjuvans für impfstoffe
EA200702077A1 (ru) Вакцина
CY1114309T1 (el) Εμβολιο ροταϊου
DE60233391D1 (de) Vakzine zum schutz von tieren gegen leishmania
TW200716169A (en) Vaccine

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties